Department of Haematology and Blood Transfusion, Lagos State University, Ikeja.
Int J Womens Health. 2011;3:423-8. doi: 10.2147/IJWH.S24850. Epub 2011 Dec 16.
Cytomegalovirus (CMV), a ubiquitous virus belonging to the herpes family, is known to be transmitted frequently to developing fetuses in pregnancy. In an immunocompromised state like pregnancy, primary infection through blood transfusion or reactivation of a latent CMV infection can cause severe illness. The study was carried out to determine the seroprevalence of the immunoglobulin G (IgG) antibody to cytomegalovirus amongst pregnant women in correlation with previous exposure to blood transfusion.
A cross sectional study was carried out amongst 179 HIV negative pregnant women attending the antenatal clinic of Lagos State University Teaching Hospital (LASUTH), Ikeja, Nigeria. Five mL of blood was collected and stored in a plain bottle, centrifuged on the same day and the serum stored at -20°C. All samples were screened for anti-CMV IgG antibodies using the enzyme linked immunosorbent assay (ELISA). Consenting participants were instructed to fill a semi-structured questionnaire to obtain demographic and other related information. Statistical analysis of the results was done using Pearson's chi squared test for analytical assessment.
A total of 97.2% of the pregnant women recruited for this study were anti-CMV IgG positive. Out of the 179 recruited for the study 174 responded to the question on previous history of blood transfusion, 14.9% of the respondents (26 of 174) had a previous history of blood transfusion and all tested positive to the anti-CMVIgG antibody. However, past history of blood transfusion and educational level were found to be insignificant to the risk of acquiring CMV infection.
The seroprevalence of the CMV antibody amongst pregnant women in this environment is high in relation to findings in other developing countries. There is the need to assess anti-CMV immunoglobulin M antibodies in pregnant women, which is a determinant of active infection.
巨细胞病毒(CMV)是一种广泛存在的疱疹病毒家族成员,已知在妊娠期间经常传播给发育中的胎儿。在妊娠等免疫功能低下的情况下,通过输血的原发感染或潜伏 CMV 感染的再激活可导致严重疾病。本研究旨在确定尼日利亚拉各斯州立大学教学医院(LASUTH)产前诊所的孕妇免疫球蛋白 G(IgG)抗体对巨细胞病毒的血清流行率,并与以往输血暴露情况相关联。
对尼日利亚拉各斯州立大学教学医院(LASUTH)产前诊所的 179 名 HIV 阴性孕妇进行了一项横断面研究。采集 5mL 血液,置于普通瓶中,当天离心,血清于-20°C 保存。所有样本均采用酶联免疫吸附试验(ELISA)筛查抗 CMV IgG 抗体。同意参加的参与者被指示填写一份半结构式问卷,以获取人口统计学和其他相关信息。使用 Pearson's chi 平方检验进行分析评估。
这项研究共招募了 179 名孕妇,其中 97.2%的孕妇抗 CMV IgG 阳性。在招募的 179 名孕妇中,有 174 名回答了关于以前输血史的问题,其中 14.9%(26 名)有以前的输血史,所有这些孕妇均对抗 CMVIgG 抗体呈阳性。然而,过去的输血史和教育水平与感染 CMV 的风险无关。
在这种环境下,孕妇的 CMV 抗体血清流行率与其他发展中国家的发现相比较高。需要评估孕妇的抗 CMV 免疫球蛋白 M 抗体,这是确定活动性感染的决定因素。